Industry, Business & Agriculture Timetable
Wednesday, February 12
09:30 – 10:00
AUDITORIUM II
WELCOME ADDRESS
09:30 – 09:35
Yossi Bornstein
Founder and Partner, Shizim Group and Cann10, Israel
09:35 – 09:45
Dr. Raquel Peyraube
Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay
09:45 – 09:50
Dr Ana Paula Martins
President of the Portuguese Pharmaceutical Society, Portugal
09:50 – 09:55
Dr Miguel Guimarães
President of the Portuguese Medical Society, Portugal
09:45 – 09:50
Dr Rui Ivo
President of Infarmed I.P., Portugal
10:00 – 10:30
AUDITORIUM II
MEDICAL GRADE CANNABIS: DEFINITION AND CONCEPTS
Chair: Prof. Lumir Hanus, Israel
Dr. Raquel Peyraube
Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay
10:30 – 11:00
AUDITORIUM I
11:00 – 12:00
AUDITORIUM III
NEW AND INNOVATIVE DELIVERY METHODS
Chair: Dr. Veronica Stahl, Dental Clinician, Expert in Implantology, Endodontics, and Restorative Dentistry, CannIBite BVBA, Belgium
11:00-11:20
CREATING NEXT-GENERATION CANNABIS-BASED THERAPIES
Dr. Oren Levy
Vice President, Research and Development, Parallel, USA
11:20-11:40
TOPICAL MEDICAL CANNABIS MEDICINES: A NEW PARADIGM FOR INTEGUMENTARY & WOUND MANAGEMENT
Dr. Vincent Maida
President & CEO, VinSan Therapeutics; Associate Professor, University of Toronto; Canada Medical Director, Hospice Vaughan, Canada
11:40-12:00
CANNABINOIDS FOR ORAL HEALTH CARE & DENTISTRY
Dr. Veronica Stahl
Dental Clinician, Expert in Implantology, Endodontics, and Restorative Dentistry, CannIBite BVBA, Belgium
12:00 – 13:20
AUDITORIUM III
ADVANCED GROWING TECHNOLOGIES
Chair: Benjamin Patock, Germany
12:00-12:20
THE IMPACT OF POST-HARVEST WATER ACTIVITY ON PRODUCT QUALITY AND CULTIVATION PROFITS
Benjamin Patock
Head of International Relations, Boveda Inc., Germany
12:20-12:40
CLIMATE CONTROL TECHNOLOGIES
Cem Guvendiren
COO, Enerama Environmental Technologies, USA
12:40-13:00
VERTICAL FARMING OF CANNABIS IN CONTAINERS
Shlomzion Halfon
Gallifrey-Canna; Grow Farm, USA
13:00-13:20
LED LIGHTING FOR MEDICAL CANNABIS CULTIVATION
Timo Bongartz
General Manager, EMEA for Fluence by OSRAM , Germany
13:20-14:10
AUDITORIUM I
14:10 – 14:55
AUDITORIUM II
THE CANNABINOID SYSTEM: WHERE DO WE STAND TODAY?
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel
14:55 – 15:55
AUDITORIUM III
PATIENTS VS. PROFIT: THE INTERACTION OF THE INDUSTRY WITH THE CLINIC
14:55 – 15:20
USING A DIGITAL PLATFORM TO EASE ACCESS TO CANNABIS RESEARCH
Elana Goldberg
Chief Content Officer, Cannigma Tree, Israel
15:20 – 15:45
ETHICAL CONSIDERATIONS FOR THE MEDICAL CANNABIS INDUSTRY
Dr. Catherine Jacobson
VP, Regulatory & Medical Affairs, Tilray, Canada
15:45 – 15:55
Q&A
15:55 – 16:10
AUDITORIUM I
16:10 – 17:30
AUDITORIUM II
LESSONS FROM REAL-WORLD CASE STUDIES
Chair: Yael Meir, Israel
16:10 – 16:30
VERTICAL INTEGRATION: FROM SEED TO PHARMA
Yael Meir, COO, Cann10. Israel
16:30 – 16:50
NON-PSYCHOACTIVE PHYTOCANNABINOIDS: MEDICAL, SUPPLEMENTS AND BEYOND
Boris Blatnik, CEO, KannaSwiss, Switzerland
16:50 – 17:10
COMPLIANCE AND REGULATIONS: MAKING THE RIGHT CHOICES
Amos Bentzur, Attorney, Amos Bentzur & Co, Israel
17:10 – 17:30
CBD AND ITS APPLICATION IN THE AUTISM SPECTRUM DISORDER
Dr. Rubens Wajnsztejn, Chief Medical Officer, HempMeds, Brasil
17:30-18:30
AUDITORIUM I
Thursday, February 13
09:30 – 10:30
AUDITORIUM III
MEDICAL CANNABIS OPERATIONS: FROM THEORY TO PRACTICE
Chair: Dr. Jan Zorgdrager, The Netherlands
09:30 – 09:55
PLANT MATERIAL: ANALYTICAL CHALLANGES AND VALIDATION OF METHODS
Bart Jansen
Business Development Manager, Bright Labs, The Netherlands
09:55 – 10:20
GMP & REGULATORY COMPLIANCE ISSUES
Dr. Jan Zorgdrager
Principal Consultant CMC and Cannabis, ProPharma Group, The Netherlands
10:20 – 10:30
Q&A
10:30-11:00
AUDITORIUM I
11:00 – 12:00
AUDITORIUM III
11:00 – 12:00
SPECIAL FOCUS ON PORTUGAL
Chair: Carlos Nunes, Portugal
WHY PORTUGAL MAY BE THE IDEAL HUB FOR MEDICAL CANNABIS IN EUROPE?
Luisa Cruz, Consultant, WiseHS, Portugal
CLINICAL TRIALS IN PORTUGAL
Prof. Alexandre Quintanilha, President of the Portuguese Ethics Committee for Clinical Research, Portugal
HOW TO NAVIGATE YOUR MEDICAL CANNABIS OPERATION INTO PORTUGAL
Carlos Nunes, Advocate, Portugal
12:00 – 13:00
AUDITORIUM II
PANEL DISCUSSION: NATIONAL AND INTERNATIONAL CANNABIS REGULATION
Moderator: Dr. Raquel Peyraube, Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay
WHERE IS THE UN GOING?
Pien Metaal
Transnational Institute, The Netherlands
CHALLENGES FOR PATIENTS AND THE INDUSTRY WITHIN COMPLEX REGULATORY FRAMEWORKS
Dr. Catherine Jacobson
VP, Regulatory & Medical Affairs, Tilray, Canada
CANNABIS REGULATIONS: A PUBLIC HEALTH PERSPECTIVE
Dr. Andres Lopez Velasco
General Director of Special Administrative Unit 23, Ministry of Health and Social Protection, Colombia
Brendan Hughes
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal
13:00-14:00
AUDITORIUM I
14:00 – 14:30
AUDITORIUM II
14:00 – 14:30
AUDITORIUM III
ORAL PRESENTATIONS: SCIENCE
14:00-14:15
USE OF CANNABIS IN PEOPLE LIVING WITH HIV IN PORTUGAL
F. De Aguiar, P. Costa, A. Silva, F. Neves, V. Duque, C. Barbosa, Portugal
14:15-14:30
EVALUATION OF ANTICANCER PROPERTIES OF DIFFERENT EXTRACTS OF CANNABIS SATIVA CULTIVATED IN PAKISTAN AGAINST SOME COMMON CANCERS: A STUDY PROTOCOL
G. Afshan, S. Khan, R. Khan, S. Siddiqi, Pakistan
ORAL PRESENTATIONS: SCIENCE/ BUSINESS
14:00 – 14:10
EFFECTS OF CBD ON DIABETES AND LIPID AND KIDNEY FUNCTION
R. Love, C. Thirlwell, Canada
14:10-14:20
THE CHALLENGES OF TRANSDERMAL DELIVERY OF CANNABINOIDS
J. Riggle, USA
14:20-14:30
SOLVING THE DILEMMA OF POLYPHARMACY WITH PATIENT-BASED MEDICAL CANNABIS REGIMENS: HARM REDUCTION IN THE CANADIAN VETERAN POPULATION
C. Thirlwell, R. Love, R. Rivas, S. Greenspan, H. Shulman, Canada
14:30 – 15:30
AUDITORIUM III
IDEAL EUROPEAN LOCATIONS FOR MEDICAL CANNABIS OPERATIONS
14:30 – 14:50
Portugal: An Evolving European Hub
Eduardo Sampaio
CEO, Piauhy Labs, Portugal
14:50- 15:10
ALL EYES ON GERMANY
Joscha Krauss
CEO, MH Medical Hemp GmbH, Germany
15:10 – 15:30
THE LANDSCAPE OF THE MEDICAL CANNABIS MARKET IN ISRAEL
Yossi Bornstein
Conference Co-Chair; Founder and Director, Cann10, Israel
15:30-15:45
AUDITORIUM I
15:45 – 16:15
AUDITORIUM II
KEYNOTE LECTURE: ARE CANNABIS & CANNABINOIDS A RISK OR A BENEFIT FOR MENTAL HEALTH?
Chair: Raquel Peyraube, Uruguay
Dr. Francisco Guimaraes, Department of Pharmacology, University of São Paulo, Brazil
16:15 – 16:30
AUDITORIUM II
CLOSING SESSION
Yael Meir
COO, Cann10. Israel
Dr. Raquel Peyraube
Director of Public Policy and Health, Plena Global, Member of the IACM EC (International Association for Cannabinoid Medicines), Uruguay